nodes	percent_of_prediction	percent_of_DWPC	metapath
Ceftaroline fosamil—Cefepime—SLC15A2—multiple sclerosis	0.0188	0.266	CrCbGaD
Ceftaroline fosamil—Cefixime—SLC15A2—multiple sclerosis	0.0147	0.208	CrCbGaD
Ceftaroline fosamil—Ceftazidime—SLC15A2—multiple sclerosis	0.0138	0.196	CrCbGaD
Ceftaroline fosamil—Angiopathy—Fingolimod—multiple sclerosis	0.0131	0.014	CcSEcCtD
Ceftaroline fosamil—Palpitations—Fingolimod—multiple sclerosis	0.0111	0.0119	CcSEcCtD
Ceftaroline fosamil—Cefotaxime—SLC15A2—multiple sclerosis	0.0106	0.15	CrCbGaD
Ceftaroline fosamil—Unspecified disorder of skin and subcutaneous tissue—Fingolimod—multiple sclerosis	0.0106	0.0114	CcSEcCtD
Ceftaroline fosamil—Hyperkalaemia—Mitoxantrone—multiple sclerosis	0.0105	0.0113	CcSEcCtD
Ceftaroline fosamil—Ceftriaxone—SLC15A2—multiple sclerosis	0.0105	0.148	CrCbGaD
Ceftaroline fosamil—Eosinophilia—Cladribine—multiple sclerosis	0.0101	0.0109	CcSEcCtD
Ceftaroline fosamil—Nervous system disorder—Fingolimod—multiple sclerosis	0.01	0.0108	CcSEcCtD
Ceftaroline fosamil—Skin disorder—Fingolimod—multiple sclerosis	0.00993	0.0107	CcSEcCtD
Ceftaroline fosamil—Neutropenia—Cladribine—multiple sclerosis	0.00953	0.0103	CcSEcCtD
Ceftaroline fosamil—Infestation—Cladribine—multiple sclerosis	0.00909	0.00978	CcSEcCtD
Ceftaroline fosamil—Infestation NOS—Cladribine—multiple sclerosis	0.00909	0.00978	CcSEcCtD
Ceftaroline fosamil—Phlebitis—Mitoxantrone—multiple sclerosis	0.009	0.00968	CcSEcCtD
Ceftaroline fosamil—Renal failure—Cladribine—multiple sclerosis	0.00893	0.00961	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal disorder—Fingolimod—multiple sclerosis	0.00883	0.0095	CcSEcCtD
Ceftaroline fosamil—Hepatobiliary disease—Cladribine—multiple sclerosis	0.00859	0.00925	CcSEcCtD
Ceftaroline fosamil—Urinary tract disorder—Cladribine—multiple sclerosis	0.00805	0.00867	CcSEcCtD
Ceftaroline fosamil—Urethral disorder—Cladribine—multiple sclerosis	0.008	0.0086	CcSEcCtD
Ceftaroline fosamil—Angiopathy—Cladribine—multiple sclerosis	0.0074	0.00796	CcSEcCtD
Ceftaroline fosamil—Infestation—Azathioprine—multiple sclerosis	0.00739	0.00795	CcSEcCtD
Ceftaroline fosamil—Infestation NOS—Azathioprine—multiple sclerosis	0.00739	0.00795	CcSEcCtD
Ceftaroline fosamil—Immune system disorder—Cladribine—multiple sclerosis	0.00737	0.00793	CcSEcCtD
Ceftaroline fosamil—Pruritus—Fingolimod—multiple sclerosis	0.00723	0.00778	CcSEcCtD
Ceftaroline fosamil—Malnutrition—Cladribine—multiple sclerosis	0.0071	0.00764	CcSEcCtD
Ceftaroline fosamil—Erythema—Cladribine—multiple sclerosis	0.0071	0.00764	CcSEcCtD
Ceftaroline fosamil—Hypokalaemia—Mitoxantrone—multiple sclerosis	0.00705	0.00759	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Fingolimod—multiple sclerosis	0.00699	0.00753	CcSEcCtD
Ceftaroline fosamil—Hepatobiliary disease—Azathioprine—multiple sclerosis	0.00699	0.00752	CcSEcCtD
Ceftaroline fosamil—Dizziness—Fingolimod—multiple sclerosis	0.00676	0.00727	CcSEcCtD
Ceftaroline fosamil—Anaemia—Cladribine—multiple sclerosis	0.00656	0.00706	CcSEcCtD
Ceftaroline fosamil—Headache—Fingolimod—multiple sclerosis	0.0064	0.00689	CcSEcCtD
Ceftaroline fosamil—Neutropenia—Mitoxantrone—multiple sclerosis	0.00626	0.00674	CcSEcCtD
Ceftaroline fosamil—Hyperglycaemia—Mitoxantrone—multiple sclerosis	0.00604	0.0065	CcSEcCtD
Ceftaroline fosamil—Unspecified disorder of skin and subcutaneous tissue—Cladribine—multiple sclerosis	0.006	0.00646	CcSEcCtD
Ceftaroline fosamil—Immune system disorder—Azathioprine—multiple sclerosis	0.00599	0.00645	CcSEcCtD
Ceftaroline fosamil—Renal failure—Mitoxantrone—multiple sclerosis	0.00587	0.00632	CcSEcCtD
Ceftaroline fosamil—Nervous system disorder—Cladribine—multiple sclerosis	0.00568	0.00611	CcSEcCtD
Ceftaroline fosamil—Thrombocytopenia—Cladribine—multiple sclerosis	0.00567	0.0061	CcSEcCtD
Ceftaroline fosamil—Skin disorder—Cladribine—multiple sclerosis	0.00563	0.00606	CcSEcCtD
Ceftaroline fosamil—Bradycardia—Mitoxantrone—multiple sclerosis	0.00546	0.00587	CcSEcCtD
Ceftaroline fosamil—Hepatitis—Mitoxantrone—multiple sclerosis	0.00536	0.00577	CcSEcCtD
Ceftaroline fosamil—Anaemia—Azathioprine—multiple sclerosis	0.00534	0.00574	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal disorder—Cladribine—multiple sclerosis	0.005	0.00538	CcSEcCtD
Ceftaroline fosamil—Constipation—Cladribine—multiple sclerosis	0.00496	0.00533	CcSEcCtD
Ceftaroline fosamil—Pain—Cladribine—multiple sclerosis	0.00496	0.00533	CcSEcCtD
Ceftaroline fosamil—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—multiple sclerosis	0.00488	0.00525	CcSEcCtD
Ceftaroline fosamil—Hypokalaemia—Betamethasone—multiple sclerosis	0.00483	0.0052	CcSEcCtD
Ceftaroline fosamil—Hypokalaemia—Dexamethasone—multiple sclerosis	0.00483	0.0052	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Cladribine—multiple sclerosis	0.00474	0.0051	CcSEcCtD
Ceftaroline fosamil—Erythema—Mitoxantrone—multiple sclerosis	0.00467	0.00502	CcSEcCtD
Ceftaroline fosamil—Thrombocytopenia—Azathioprine—multiple sclerosis	0.00461	0.00496	CcSEcCtD
Ceftaroline fosamil—Urticaria—Cladribine—multiple sclerosis	0.0046	0.00495	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Cladribine—multiple sclerosis	0.00458	0.00493	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Cladribine—multiple sclerosis	0.00458	0.00493	CcSEcCtD
Ceftaroline fosamil—Skin disorder—Azathioprine—multiple sclerosis	0.00458	0.00492	CcSEcCtD
Ceftaroline fosamil—Infestation NOS—Methylprednisolone—multiple sclerosis	0.0045	0.00484	CcSEcCtD
Ceftaroline fosamil—Infestation—Methylprednisolone—multiple sclerosis	0.0045	0.00484	CcSEcCtD
Ceftaroline fosamil—Bradycardia—Prednisolone—multiple sclerosis	0.00448	0.00482	CcSEcCtD
Ceftaroline fosamil—Anaemia—Mitoxantrone—multiple sclerosis	0.00431	0.00464	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Cladribine—multiple sclerosis	0.00427	0.00459	CcSEcCtD
Ceftaroline fosamil—Hypokalaemia—Prednisone—multiple sclerosis	0.0042	0.00452	CcSEcCtD
Ceftaroline fosamil—Hyperglycaemia—Dexamethasone—multiple sclerosis	0.00414	0.00445	CcSEcCtD
Ceftaroline fosamil—Hyperglycaemia—Betamethasone—multiple sclerosis	0.00414	0.00445	CcSEcCtD
Ceftaroline fosamil—Bradycardia—Triamcinolone—multiple sclerosis	0.00412	0.00443	CcSEcCtD
Ceftaroline fosamil—Bradycardia—Methylprednisolone—multiple sclerosis	0.00411	0.00442	CcSEcCtD
Ceftaroline fosamil—Pruritus—Cladribine—multiple sclerosis	0.0041	0.00441	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal disorder—Azathioprine—multiple sclerosis	0.00407	0.00438	CcSEcCtD
Ceftaroline fosamil—Convulsion—Mitoxantrone—multiple sclerosis	0.00404	0.00435	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Cladribine—multiple sclerosis	0.00396	0.00427	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Azathioprine—multiple sclerosis	0.00385	0.00415	CcSEcCtD
Ceftaroline fosamil—Dizziness—Cladribine—multiple sclerosis	0.00383	0.00412	CcSEcCtD
Ceftaroline fosamil—Erythema—Prednisolone—multiple sclerosis	0.00383	0.00412	CcSEcCtD
Ceftaroline fosamil—Anaphylactic shock—Mitoxantrone—multiple sclerosis	0.00381	0.0041	CcSEcCtD
Ceftaroline fosamil—Bradycardia—Dexamethasone—multiple sclerosis	0.00374	0.00402	CcSEcCtD
Ceftaroline fosamil—Bradycardia—Betamethasone—multiple sclerosis	0.00374	0.00402	CcSEcCtD
Ceftaroline fosamil—Neutropenia—Prednisone—multiple sclerosis	0.00373	0.00402	CcSEcCtD
Ceftaroline fosamil—Thrombocytopenia—Mitoxantrone—multiple sclerosis	0.00373	0.00401	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Azathioprine—multiple sclerosis	0.00372	0.00401	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Azathioprine—multiple sclerosis	0.00372	0.00401	CcSEcCtD
Ceftaroline fosamil—Skin disorder—Mitoxantrone—multiple sclerosis	0.0037	0.00398	CcSEcCtD
Ceftaroline fosamil—Vomiting—Cladribine—multiple sclerosis	0.00368	0.00396	CcSEcCtD
Ceftaroline fosamil—Angiopathy—Methylprednisolone—multiple sclerosis	0.00366	0.00394	CcSEcCtD
Ceftaroline fosamil—Rash—Cladribine—multiple sclerosis	0.00365	0.00393	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Cladribine—multiple sclerosis	0.00365	0.00393	CcSEcCtD
Ceftaroline fosamil—Immune system disorder—Methylprednisolone—multiple sclerosis	0.00365	0.00392	CcSEcCtD
Ceftaroline fosamil—Headache—Cladribine—multiple sclerosis	0.00363	0.00391	CcSEcCtD
Ceftaroline fosamil—Hyperglycaemia—Prednisone—multiple sclerosis	0.0036	0.00388	CcSEcCtD
Ceftaroline fosamil—Erythema—Triamcinolone—multiple sclerosis	0.00352	0.00379	CcSEcCtD
Ceftaroline fosamil—Malnutrition—Methylprednisolone—multiple sclerosis	0.00351	0.00378	CcSEcCtD
Ceftaroline fosamil—Erythema—Methylprednisolone—multiple sclerosis	0.00351	0.00378	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Azathioprine—multiple sclerosis	0.00347	0.00374	CcSEcCtD
Ceftaroline fosamil—Nausea—Cladribine—multiple sclerosis	0.00344	0.0037	CcSEcCtD
Ceftaroline fosamil—Angiopathy—Dexamethasone—multiple sclerosis	0.00333	0.00358	CcSEcCtD
Ceftaroline fosamil—Angiopathy—Betamethasone—multiple sclerosis	0.00333	0.00358	CcSEcCtD
Ceftaroline fosamil—Convulsion—Prednisolone—multiple sclerosis	0.00332	0.00357	CcSEcCtD
Ceftaroline fosamil—Eosinophilia—Methotrexate—multiple sclerosis	0.0033	0.00356	CcSEcCtD
Ceftaroline fosamil—Pain—Mitoxantrone—multiple sclerosis	0.00326	0.0035	CcSEcCtD
Ceftaroline fosamil—Constipation—Mitoxantrone—multiple sclerosis	0.00326	0.0035	CcSEcCtD
Ceftaroline fosamil—Bradycardia—Prednisone—multiple sclerosis	0.00325	0.0035	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Azathioprine—multiple sclerosis	0.00322	0.00347	CcSEcCtD
Ceftaroline fosamil—Erythema—Dexamethasone—multiple sclerosis	0.00319	0.00344	CcSEcCtD
Ceftaroline fosamil—Erythema—Betamethasone—multiple sclerosis	0.00319	0.00344	CcSEcCtD
Ceftaroline fosamil—Anaphylactic shock—Prednisolone—multiple sclerosis	0.00312	0.00336	CcSEcCtD
Ceftaroline fosamil—Neutropenia—Methotrexate—multiple sclerosis	0.00312	0.00336	CcSEcCtD
Ceftaroline fosamil—Dizziness—Azathioprine—multiple sclerosis	0.00312	0.00335	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.00311	0.00335	CcSEcCtD
Ceftaroline fosamil—Convulsion—Triamcinolone—multiple sclerosis	0.00305	0.00328	CcSEcCtD
Ceftaroline fosamil—Convulsion—Methylprednisolone—multiple sclerosis	0.00304	0.00328	CcSEcCtD
Ceftaroline fosamil—Urticaria—Mitoxantrone—multiple sclerosis	0.00303	0.00326	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Mitoxantrone—multiple sclerosis	0.00301	0.00324	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Mitoxantrone—multiple sclerosis	0.00301	0.00324	CcSEcCtD
Ceftaroline fosamil—Vomiting—Azathioprine—multiple sclerosis	0.003	0.00322	CcSEcCtD
Ceftaroline fosamil—Infestation NOS—Methotrexate—multiple sclerosis	0.00298	0.0032	CcSEcCtD
Ceftaroline fosamil—Infestation—Methotrexate—multiple sclerosis	0.00298	0.0032	CcSEcCtD
Ceftaroline fosamil—Rash—Azathioprine—multiple sclerosis	0.00297	0.0032	CcSEcCtD
Ceftaroline fosamil—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.00297	0.0032	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Azathioprine—multiple sclerosis	0.00297	0.00319	CcSEcCtD
Ceftaroline fosamil—Headache—Azathioprine—multiple sclerosis	0.00295	0.00318	CcSEcCtD
Ceftaroline fosamil—Renal failure—Methotrexate—multiple sclerosis	0.00292	0.00315	CcSEcCtD
Ceftaroline fosamil—Angiopathy—Prednisone—multiple sclerosis	0.0029	0.00312	CcSEcCtD
Ceftaroline fosamil—Immune system disorder—Prednisone—multiple sclerosis	0.00289	0.00311	CcSEcCtD
Ceftaroline fosamil—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.00287	0.00309	CcSEcCtD
Ceftaroline fosamil—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.00287	0.00309	CcSEcCtD
Ceftaroline fosamil—Hepatobiliary disease—Methotrexate—multiple sclerosis	0.00281	0.00303	CcSEcCtD
Ceftaroline fosamil—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.00281	0.00303	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.00281	0.00302	CcSEcCtD
Ceftaroline fosamil—Nausea—Azathioprine—multiple sclerosis	0.0028	0.00301	CcSEcCtD
Ceftaroline fosamil—Skin disorder—Methylprednisolone—multiple sclerosis	0.00279	0.003	CcSEcCtD
Ceftaroline fosamil—Malnutrition—Prednisone—multiple sclerosis	0.00278	0.00299	CcSEcCtD
Ceftaroline fosamil—Erythema—Prednisone—multiple sclerosis	0.00278	0.00299	CcSEcCtD
Ceftaroline fosamil—Convulsion—Betamethasone—multiple sclerosis	0.00277	0.00298	CcSEcCtD
Ceftaroline fosamil—Convulsion—Dexamethasone—multiple sclerosis	0.00277	0.00298	CcSEcCtD
Ceftaroline fosamil—Pain—Prednisolone—multiple sclerosis	0.00267	0.00288	CcSEcCtD
Ceftaroline fosamil—Hepatitis—Methotrexate—multiple sclerosis	0.00267	0.00287	CcSEcCtD
Ceftaroline fosamil—Urinary tract disorder—Methotrexate—multiple sclerosis	0.00264	0.00284	CcSEcCtD
Ceftaroline fosamil—Urethral disorder—Methotrexate—multiple sclerosis	0.00262	0.00282	CcSEcCtD
Ceftaroline fosamil—Anaphylactic shock—Betamethasone—multiple sclerosis	0.00261	0.00281	CcSEcCtD
Ceftaroline fosamil—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.00261	0.00281	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Mitoxantrone—multiple sclerosis	0.00261	0.0028	CcSEcCtD
Ceftaroline fosamil—Anaemia—Prednisone—multiple sclerosis	0.00257	0.00277	CcSEcCtD
Ceftaroline fosamil—Nervous system disorder—Betamethasone—multiple sclerosis	0.00256	0.00275	CcSEcCtD
Ceftaroline fosamil—Nervous system disorder—Dexamethasone—multiple sclerosis	0.00256	0.00275	CcSEcCtD
Ceftaroline fosamil—Thrombocytopenia—Betamethasone—multiple sclerosis	0.00255	0.00275	CcSEcCtD
Ceftaroline fosamil—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.00255	0.00275	CcSEcCtD
Ceftaroline fosamil—Urticaria—Prednisolone—multiple sclerosis	0.00248	0.00267	CcSEcCtD
Ceftaroline fosamil—Pain—Triamcinolone—multiple sclerosis	0.00246	0.00264	CcSEcCtD
Ceftaroline fosamil—Angiopathy—Methotrexate—multiple sclerosis	0.00242	0.00261	CcSEcCtD
Ceftaroline fosamil—Vomiting—Mitoxantrone—multiple sclerosis	0.00242	0.00261	CcSEcCtD
Ceftaroline fosamil—Immune system disorder—Methotrexate—multiple sclerosis	0.00241	0.0026	CcSEcCtD
Ceftaroline fosamil—Convulsion—Prednisone—multiple sclerosis	0.00241	0.00259	CcSEcCtD
Ceftaroline fosamil—Rash—Mitoxantrone—multiple sclerosis	0.0024	0.00258	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Mitoxantrone—multiple sclerosis	0.0024	0.00258	CcSEcCtD
Ceftaroline fosamil—Headache—Mitoxantrone—multiple sclerosis	0.00239	0.00257	CcSEcCtD
Ceftaroline fosamil—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.00235	0.00253	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.00234	0.00252	CcSEcCtD
Ceftaroline fosamil—Malnutrition—Methotrexate—multiple sclerosis	0.00233	0.0025	CcSEcCtD
Ceftaroline fosamil—Erythema—Methotrexate—multiple sclerosis	0.00233	0.0025	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Prednisolone—multiple sclerosis	0.0023	0.00248	CcSEcCtD
Ceftaroline fosamil—Urticaria—Triamcinolone—multiple sclerosis	0.00228	0.00246	CcSEcCtD
Ceftaroline fosamil—Urticaria—Methylprednisolone—multiple sclerosis	0.00228	0.00245	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Triamcinolone—multiple sclerosis	0.00227	0.00244	CcSEcCtD
Ceftaroline fosamil—Anaphylactic shock—Prednisone—multiple sclerosis	0.00227	0.00244	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Methylprednisolone—multiple sclerosis	0.00227	0.00244	CcSEcCtD
Ceftaroline fosamil—Nausea—Mitoxantrone—multiple sclerosis	0.00226	0.00243	CcSEcCtD
Ceftaroline fosamil—Ceftriaxone—ALB—multiple sclerosis	0.00225	0.0319	CrCbGaD
Ceftaroline fosamil—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.00225	0.00242	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.00225	0.00242	CcSEcCtD
Ceftaroline fosamil—Pain—Betamethasone—multiple sclerosis	0.00223	0.0024	CcSEcCtD
Ceftaroline fosamil—Pain—Dexamethasone—multiple sclerosis	0.00223	0.0024	CcSEcCtD
Ceftaroline fosamil—Nervous system disorder—Prednisone—multiple sclerosis	0.00223	0.0024	CcSEcCtD
Ceftaroline fosamil—Skin disorder—Prednisone—multiple sclerosis	0.00221	0.00237	CcSEcCtD
Ceftaroline fosamil—Anaemia—Methotrexate—multiple sclerosis	0.00215	0.00231	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.00213	0.00229	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.00213	0.00229	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Triamcinolone—multiple sclerosis	0.00212	0.00228	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.00211	0.00227	CcSEcCtD
Ceftaroline fosamil—Urticaria—Betamethasone—multiple sclerosis	0.00207	0.00223	CcSEcCtD
Ceftaroline fosamil—Urticaria—Dexamethasone—multiple sclerosis	0.00207	0.00223	CcSEcCtD
Ceftaroline fosamil—Dizziness—Prednisolone—multiple sclerosis	0.00207	0.00222	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Dexamethasone—multiple sclerosis	0.00206	0.00222	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Dexamethasone—multiple sclerosis	0.00206	0.00222	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Betamethasone—multiple sclerosis	0.00206	0.00222	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Betamethasone—multiple sclerosis	0.00206	0.00222	CcSEcCtD
Ceftaroline fosamil—Pruritus—Triamcinolone—multiple sclerosis	0.00203	0.00219	CcSEcCtD
Ceftaroline fosamil—Pruritus—Methylprednisolone—multiple sclerosis	0.00203	0.00218	CcSEcCtD
Ceftaroline fosamil—Convulsion—Methotrexate—multiple sclerosis	0.00201	0.00217	CcSEcCtD
Ceftaroline fosamil—Rash—Prednisolone—multiple sclerosis	0.00197	0.00212	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Prednisolone—multiple sclerosis	0.00197	0.00212	CcSEcCtD
Ceftaroline fosamil—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.00197	0.00212	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Methylprednisolone—multiple sclerosis	0.00196	0.00211	CcSEcCtD
Ceftaroline fosamil—Headache—Prednisolone—multiple sclerosis	0.00196	0.00211	CcSEcCtD
Ceftaroline fosamil—Constipation—Prednisone—multiple sclerosis	0.00194	0.00209	CcSEcCtD
Ceftaroline fosamil—Dizziness—Triamcinolone—multiple sclerosis	0.0019	0.00204	CcSEcCtD
Ceftaroline fosamil—Anaphylactic shock—Methotrexate—multiple sclerosis	0.0019	0.00204	CcSEcCtD
Ceftaroline fosamil—Dizziness—Methylprednisolone—multiple sclerosis	0.0019	0.00204	CcSEcCtD
Ceftaroline fosamil—Nervous system disorder—Methotrexate—multiple sclerosis	0.00186	0.002	CcSEcCtD
Ceftaroline fosamil—Thrombocytopenia—Methotrexate—multiple sclerosis	0.00186	0.002	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Prednisone—multiple sclerosis	0.00186	0.002	CcSEcCtD
Ceftaroline fosamil—Nausea—Prednisolone—multiple sclerosis	0.00186	0.002	CcSEcCtD
Ceftaroline fosamil—Pruritus—Betamethasone—multiple sclerosis	0.00184	0.00198	CcSEcCtD
Ceftaroline fosamil—Pruritus—Dexamethasone—multiple sclerosis	0.00184	0.00198	CcSEcCtD
Ceftaroline fosamil—Skin disorder—Methotrexate—multiple sclerosis	0.00184	0.00198	CcSEcCtD
Ceftaroline fosamil—Vomiting—Triamcinolone—multiple sclerosis	0.00183	0.00197	CcSEcCtD
Ceftaroline fosamil—Vomiting—Methylprednisolone—multiple sclerosis	0.00182	0.00196	CcSEcCtD
Ceftaroline fosamil—Rash—Triamcinolone—multiple sclerosis	0.00181	0.00195	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Triamcinolone—multiple sclerosis	0.00181	0.00195	CcSEcCtD
Ceftaroline fosamil—Rash—Methylprednisolone—multiple sclerosis	0.00181	0.00195	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Methylprednisolone—multiple sclerosis	0.00181	0.00194	CcSEcCtD
Ceftaroline fosamil—Urticaria—Prednisone—multiple sclerosis	0.0018	0.00194	CcSEcCtD
Ceftaroline fosamil—Headache—Triamcinolone—multiple sclerosis	0.0018	0.00194	CcSEcCtD
Ceftaroline fosamil—Headache—Methylprednisolone—multiple sclerosis	0.0018	0.00193	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Prednisone—multiple sclerosis	0.0018	0.00193	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Prednisone—multiple sclerosis	0.0018	0.00193	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Dexamethasone—multiple sclerosis	0.00178	0.00192	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Betamethasone—multiple sclerosis	0.00178	0.00192	CcSEcCtD
Ceftaroline fosamil—Dizziness—Betamethasone—multiple sclerosis	0.00172	0.00186	CcSEcCtD
Ceftaroline fosamil—Dizziness—Dexamethasone—multiple sclerosis	0.00172	0.00186	CcSEcCtD
Ceftaroline fosamil—Nausea—Triamcinolone—multiple sclerosis	0.00171	0.00184	CcSEcCtD
Ceftaroline fosamil—Nausea—Methylprednisolone—multiple sclerosis	0.0017	0.00183	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Prednisone—multiple sclerosis	0.00167	0.0018	CcSEcCtD
Ceftaroline fosamil—Vomiting—Betamethasone—multiple sclerosis	0.00166	0.00178	CcSEcCtD
Ceftaroline fosamil—Vomiting—Dexamethasone—multiple sclerosis	0.00166	0.00178	CcSEcCtD
Ceftaroline fosamil—Rash—Betamethasone—multiple sclerosis	0.00164	0.00177	CcSEcCtD
Ceftaroline fosamil—Rash—Dexamethasone—multiple sclerosis	0.00164	0.00177	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Dexamethasone—multiple sclerosis	0.00164	0.00177	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Betamethasone—multiple sclerosis	0.00164	0.00177	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.00164	0.00176	CcSEcCtD
Ceftaroline fosamil—Headache—Dexamethasone—multiple sclerosis	0.00163	0.00176	CcSEcCtD
Ceftaroline fosamil—Headache—Betamethasone—multiple sclerosis	0.00163	0.00176	CcSEcCtD
Ceftaroline fosamil—Pain—Methotrexate—multiple sclerosis	0.00162	0.00175	CcSEcCtD
Ceftaroline fosamil—Pruritus—Prednisone—multiple sclerosis	0.00161	0.00173	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Prednisone—multiple sclerosis	0.00155	0.00167	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.00155	0.00167	CcSEcCtD
Ceftaroline fosamil—Nausea—Betamethasone—multiple sclerosis	0.00155	0.00167	CcSEcCtD
Ceftaroline fosamil—Nausea—Dexamethasone—multiple sclerosis	0.00155	0.00167	CcSEcCtD
Ceftaroline fosamil—Urticaria—Methotrexate—multiple sclerosis	0.00151	0.00162	CcSEcCtD
Ceftaroline fosamil—Dizziness—Prednisone—multiple sclerosis	0.0015	0.00162	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Methotrexate—multiple sclerosis	0.0015	0.00161	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Methotrexate—multiple sclerosis	0.0015	0.00161	CcSEcCtD
Ceftaroline fosamil—Vomiting—Prednisone—multiple sclerosis	0.00144	0.00155	CcSEcCtD
Ceftaroline fosamil—Rash—Prednisone—multiple sclerosis	0.00143	0.00154	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Prednisone—multiple sclerosis	0.00143	0.00154	CcSEcCtD
Ceftaroline fosamil—Headache—Prednisone—multiple sclerosis	0.00142	0.00153	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Methotrexate—multiple sclerosis	0.0014	0.0015	CcSEcCtD
Ceftaroline fosamil—Nausea—Prednisone—multiple sclerosis	0.00135	0.00145	CcSEcCtD
Ceftaroline fosamil—Pruritus—Methotrexate—multiple sclerosis	0.00134	0.00144	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Methotrexate—multiple sclerosis	0.0013	0.0014	CcSEcCtD
Ceftaroline fosamil—Dizziness—Methotrexate—multiple sclerosis	0.00125	0.00135	CcSEcCtD
Ceftaroline fosamil—Vomiting—Methotrexate—multiple sclerosis	0.00121	0.0013	CcSEcCtD
Ceftaroline fosamil—Rash—Methotrexate—multiple sclerosis	0.0012	0.00129	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Methotrexate—multiple sclerosis	0.0012	0.00129	CcSEcCtD
Ceftaroline fosamil—Headache—Methotrexate—multiple sclerosis	0.00119	0.00128	CcSEcCtD
Ceftaroline fosamil—Nausea—Methotrexate—multiple sclerosis	0.00113	0.00121	CcSEcCtD
